-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A0LhTv5rdslorSKBHwu2LpoQcuhP99jLEJkg+qRXmqR9CFIfsN9KQXrSe9x02+Yk DbNCTDhU6wGC51L+XmpZPA== 0000912057-97-023315.txt : 19970703 0000912057-97-023315.hdr.sgml : 19970703 ACCESSION NUMBER: 0000912057-97-023315 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970702 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIVRA INC CENTRAL INDEX KEY: 0000850882 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 943096645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-10261 FILM NUMBER: 97635477 BUSINESS ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 500 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 4155775700 MAIL ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 500 CITY: SAN MATEO STATE: CA ZIP: 94404 15-12B 1 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 1-10261 ---------- DIALYSIS HOLDINGS, INC. (formerly known as Vivra Incorporated) ------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) 1850 GATEWAY DRIVE, SUITE 500, SAN MATEO, CALIFORNIA 94404 (415) 577-5700 ------------------------------------------------------------------------- (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) COMMON STOCK, PAR VALUE $0.01 PER SHARE PREFERRED STOCK PURCHASE RIGHTS ------------------------------------------------------------------------- (Title of each class of securities covered by this Form) NONE ------------------------------------------------------------------------- (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4(a)(1)(i) X Rule 12h-3(b)(1)(i) X --- --- Rule 12g-4(a)(1)(ii)___ Rule 12h-3(b)(1)(ii)___ Rule 12g-4(a)(2)(i) ___ Rule 12h-3(b)(2)(i) ___ Rule 12g-4(a)(2)(ii)___ Rule 12h-3(b)(2)(ii)___ Rule 15d-6 ___ Approximate number of holders of record as of the certification or notice date: 1 -------- Pursuant to the requirements of the Securities Exchange Act of 1934 (NAME OF REGISTRANT AS SPECIFIED IN CHARTER) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. Date: JULY 2, 1997 By: /s/ Ralph Z. Levy, Jr. ------------ ------------------------ Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature. -----END PRIVACY-ENHANCED MESSAGE-----